Latest news with #DanielChan
South China Morning Post
3 days ago
- Entertainment
- South China Morning Post
Singapore firms gamify ageing well, 500 illustrations of toast: 7 Lifestyle highlights
We have selected seven Lifestyle and Culture stories from the past seven days that resonated with our readers. If you would like to see more of our reporting, please consider subscribing The Busan International Film Festival in South Korea celebrates its 30th anniversary in September with an expanded and revamped programme. Singaporeans are embracing insurance companies' health programmes that combine incentives, challenges and support for healthier lives. The bouchon gratiné is a favourite snack on Réunion Island, made with a baguette, chilli sauce, siu mai and melted cheese. Photo: X/ LudovicShooter While going over his business ledgers, Daniel Chan, the fourth-generation owner of Hong Kong's Koon Chun sauce factory, made an interesting discovery. One of his biggest groups of clients came from Réunion Island, a French department in the Indian Ocean, east of Madagascar, with a population just shy of 900,000.
South China Morning Post
10-08-2025
- Business
- South China Morning Post
How a Hong Kong chilli sauce became a sandwich favourite 8,000km away on Réunion Island
While going over his business ledgers, Daniel Chan, the third-generation owner of Hong Kong's Koon Chun sauce factory, made an interesting discovery. One of his biggest groups of clients came from Réunion Island, a French department in the Indian Ocean, east of Madagascar, with a population just shy of 900,000. Advertisement 'We were sending two containers of soy, oyster and chilli sauce there every month,' Chan says. 'I was so curious why they would like our sauce so much.' Chan took the 36-hour journey to Réunion, with stops in Mauritius and South Africa along the way, to find out. Réunion Island was discovered by Arab and Portuguese sailors before the French claimed it in 1642, naming it Île Bourbon. It was initially used as a supply stop for ships, before the French East India Company began developing plantations, using slave labour from Africa and Madagascar to grow coffee, spices and later sugar. The island was renamed Réunion during the French Revolution in 1793 but reverted to Bourbon under Napoleon before finally becoming Réunion again in 1848, when France abolished slavery. The 19th century saw the arrival of indentured labourers from India, China and Southeast Asia, shaping its multicultural society. Advertisement In 1946, Réunion became an overseas French department. Today, its history of colonisation, slavery and immigration is reflected in its Creole culture, blending African, European, Indian and Chinese influences.
South China Morning Post
19-06-2025
- Sport
- South China Morning Post
Hong Kong ex-Paralympian Daniel Chan aims to improve badminton players' lives in new role
Two-time Paralympic medallist Daniel Chan Ho-yuen hoped to push for more resources from the Badminton World Federation (BWF) to further develop the sport worldwide after being appointed chair of the Para Badminton Athletes' Commission and a BWF Council member last Thursday. Advertisement While his chairmanship is technically only until re-elections in December – though there was an understanding with the BWF that he would continue in the role and his re-election would be a formality – Chan intended to use his time in the position to improve the conditions for those still playing the sport. 'It wasn't even a Paralympic sport when I first started serving,' said Chan, who has been a commission member for eight years. 'It is now a sport, and people are learning more about it, but the resources are lacking and quite poor. 'We are lucky in Hong Kong because we can be full-time athletes, but that is not the case for athletes in many other countries.' Daniel Chan won a bronze medal at the Tokyo Paralympics in 2021. Photo: Hong Kong Paralympic Association Chan, who won a bronze and silver medal at the Tokyo and Paris Paralympics respectively, also said that badminton's prominence in Asia meant the sport in the region was better off than in the other continents. Advertisement 'In Europe, Africa, South America and even Oceania, where badminton isn't a prime sport or as much a part of the culture, players need to cover their own expenses to compete overseas, and this can be very expensive,' he said.
Yahoo
23-04-2025
- Business
- Yahoo
Bionic P&O Chosen as First Distributor of Ekso Indego® Personal Within the Orthotics & Prosthetics Industry
Alliance marks Ekso Bionics' first entrance into the O&P space SAN RAFAEL, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the 'Company'), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has named Bionic Prosthetics & Orthotics Group LLC ('Bionic P&O'), a leading national provider of prosthetic and orthotic solutions, as a non-exclusive Ekso Indego® Personal device distributor. Ekso Indego Personal is a wearable lower extremity powered exoskeleton that enables certain individuals living with spinal cord injuries ('SCIs') with the ability to stand and walk independently. It is the only known portable exoskeleton device to offer a modular quick connect design, which was engineered to allow users to put on and take off the device without assistance. Ekso Indego Personal is the lightest known commercial exoskeleton available offering ease of handling, transportation, and storage. Also offering an advanced gait mode, individuals with a SCI using the device have been shown to reach faster walking speeds, granting them a new level of independence in the community. 'This exciting new commercial alliance with a recognized leader like Bionic P&O aligns squarely with our mission of improving health and quality of life with advanced robotics designed to enhance, amplify, and restore human function,' commented Scott Davis, the Company's Chief Executive Officer. 'From a business perspective, the successful marketing and distribution of an innovative device like Ekso Indego Personal requires deep insight into the particular market dynamics, the reimbursement landscape, and above all, the needs of patients served within the community. I cannot think of a better choice than Bionic P&O as our first distributor for Ekso Indego Personal within the important orthotics and prosthetics industry.' 'True innovation that supports patients in reaching their goals, paired with compassionate care, is the cornerstone of Bionic P&O's success. Bionic P&O's mission is to empower individuals to live more independent and fulfilling lives. We believe the Ekso Indego Personal device will make a lasting positive impact on our patients' lives and has the potential to transform the orthotics and prosthetics industry,' said Daniel Chan, National Business Development Manager at Bionic P&O. 'We are thrilled by our alliance with Ekso Bionics. Together, we are paving the way for a future where spinal cord injury patients can not only dream of walking again, but actively work towards that goal.' About Ekso Bionics®Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Based upon its industry-leading expertise, the Company focuses on improving health and quality of life with advanced robotics designed to enhance, amplify, and restore human function. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol 'EKSO.' For more information, visit: About Bionic P&OFounded in 2007, Bionic P&O is an independent clinical practice group that now operates across 12 states: Florida, Illinois, Indiana, Kentucky, Michigan, New Jersey, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, and Wisconsin. Fully accredited by the American Board for Certification in Orthotics, Prosthetics, and Pedorthics (ABC), Bionic P&O employs certified/licensed O&P practitioners with expertise in a wide range of specialties, including advanced lower and upper limb prosthetics, lower and upper limb orthotics, spinal orthotics, pediatric orthotics, and cranial remolding orthotics. For more information, visit: Forward-Looking StatementsAny statement contained in this press release that does not describe historical facts may constitute a forward-looking statement. Forward-looking statements may include, without limitation, statements regarding the ability of Bionic P&O to distribute the Company's Ekso Indego Personal device within the orthotics and prosthetics products industry in the United States, the impact to the Company and the broader industry of the Company's partnership with Bionic P&O, the potential impacts of the Company's device to patients using the device, and the Company's ability to bolster demand for its technology and execute on its long-term growth strategy. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company's inability to obtain adequate financing to fund and grow the Company's operations and to develop or enhance the Company's technology, the Company's inability to obtain future reimbursements from CMS in a timely manner and at the expected reimbursement levels, the Company's inability to obtain insurance coverage beyond CMS, the Company's inability to obtain additional indications of use for its devices, any delay or discontinuation of the sales and distribution of Esko Indego Personal within the orthotics and prosthetics products industry, or Ekso Indego Personal risks related to product liability, recall and warranty claims. These and other factors are identified and described in more detail in the Company's filings with the U.S. Securities and Exchange Commission. To learn more about Ekso Bionics please visit the Company's website at or follow @EksoBionics on X. The Company does not undertake to update these forward-looking statements, except as required by law. Contact:Stephen KilmerInvestor RelationsDirect: (646) 274-3580Email: skilmer@ in to access your portfolio
